Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01517347
What this trial is testing

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Who this might be right for
Leukemia
Peking University People's Hospital 90
Not applicableStudy completedNCT00330538
What this trial is testing

Osteoporosis in Children With ALL

Who this might be right for
Leukemia, Lymphocytic, Acute, L1
Children's Mercy Hospital Kansas City 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652685
What this trial is testing

Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Ruijin Hospital 218
Not applicableNot Yet RecruitingNCT07691008
What this trial is testing

Wearable Data for Personalized Prognostication in Cancer: A Registry Protocol

Who this might be right for
Hematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm+1 more
City of Hope Medical Center 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT04742634
What this trial is testing

Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Myelodysplastic Syndromes
Washington University School of Medicine 209
Testing effectiveness (Phase 2)Study completedNCT00806598
What this trial is testing

Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeAplastic Anemia
M.D. Anderson Cancer Center 53
Not applicableStudy completedNCT01338363
What this trial is testing

Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists

Who this might be right for
Hospitalized Cases of Angioneurotic OedemaPneumoniaGastroenteritis+3 more
AstraZeneca 23,470
Testing effectiveness (Phase 2)Ended earlyNCT00909363
What this trial is testing

Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients

Who this might be right for
Wiskott-Aldrich SyndromeThrombocytopeniaBleeding
Weill Medical College of Cornell University 24
Testing effectiveness (Phase 2)Study completedNCT03439293
What this trial is testing

Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma
Takeda 61
Not applicableEnded earlyNCT01096121
What this trial is testing

Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children

Who this might be right for
Sickle Cell Disease
Assistance Publique - Hôpitaux de Paris 5
Not applicableWithdrawnNCT05943314
What this trial is testing

Clinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Guangzhou Bio-gene Technology Co., Ltd
Not applicableStudy completedNCT01236014
What this trial is testing

Indirect Comparison Between Eltrombopag & Romiplostim

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 1
Testing effectiveness (Phase 2)WithdrawnNCT00845104
What this trial is testing

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Testing effectiveness (Phase 2)UnknownNCT03940833
What this trial is testing

Clinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MM

Who this might be right for
Multiple Myeloma
Asclepius Technology Company Group (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Temporarily pausedNCT02910752
What this trial is testing

CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia
Shanghai Jiao Tong University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00866138
What this trial is testing

Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3

Who this might be right for
Multiple Myeloma
AB Science 24
Early research (Phase 1)Looking for participantsNCT07206758
What this trial is testing

Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Guangdong Hengrui Pharmaceutical Co., Ltd 10
Early research (Phase 1)Looking for participantsNCT06191978
What this trial is testing

A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)Ended earlyNCT02158936
What this trial is testing

Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Thrombocytopaenia
Novartis Pharmaceuticals 356
Not applicableStudy completedNCT02770534
What this trial is testing

Evaluating Thromboelastography (TEG) and ETP in Sickle Adults

Who this might be right for
Sickle Cell Disease
Guy's and St Thomas' NHS Foundation Trust 100
Next Page